Display options
Cite
Zarean M, Maraghi S, Hajjaran H, et al. Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis. Iran J Parasitol. 2015;10(1):19-29
Zarean, M., Maraghi, S., Hajjaran, H., Mohebali, M., Feiz-Hadad, M. H., & Assarehzadegan, M. A. (2015). Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis. Iranian journal of parasitology, 10(1), 19-29.
Zarean, Mehdi, et al. "Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis." Iranian journal of parasitology vol. 10,1 (2015): 19-29.
Zarean M, Maraghi S, Hajjaran H, Mohebali M, Feiz-Hadad MH, Assarehzadegan MA. Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis. Iran J Parasitol. 2015 Jan-Mar;10(1):19-29. PMID: 25904942; PMCID: PMC4403536.
Copy Download .nbib Format: NLM
Share it on

Iran J Parasitol. 2015 Jan-Mar;10(1):19-29.

Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis.

Iranian journal of parasitology

Mehdi Zarean, Sharif Maraghi, Homa Hajjaran, Mehdi Mohebali, Mohammad Hossein Feiz-Hadad, Mohammad Ali Assarehzadegan

Affiliations

  1. Department of Medical Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  2. Department of Medical Parasitology, School of Medicine, Institute of Health Research, Thalassemia and Hemoglobinopathy Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  3. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  4. Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

PMID: 25904942 PMCID: PMC4403536

Abstract

BACKGROUND: In this study, two-dimensional gel electrophoresis (2-DE) method was applied to determine and compare the protein spots expressed in the two field isolates of Leishmania major and recovered from the patients who were clinically sensitive and resistant to Glucantime® treatment.

METHODS: Leishmania parasites were isolated from the cutaneous lesions of two CL infected patients in Shiraz, south of Iran. The species of the two isolates were identified as L. major using Nested-PCR. Sensitivity (Sh-214S) and resistance (Sh-120R) of the two isolates to meglumine antimonite were checked by the standard in vitro assays. Both sensitive and resistant L. major isolates were harvested in RPMI 1640 medium. Protein extractions were performed using TCA/Acetone method and the protein spots were determined by a two-dimensional gel electrophoresis (2-DE). The gels were stained with silver nitrate and analyzed by Image Master 2D Melanie-6 software.

RESULTS: About 2967 protein spots were detected. Overall, 89 protein spots represented considerable changes of expression in the resistant isolate of L. major compared to the sensitive isolate. Of these, 60 and 29 protein spots were up-and down regulated, respectively. In addition, 11 protein spots present in the resistant isolate were noticed to be absent in the sensitive isolate.

CONCLUSION: A number of proteins showed significant changes of expression in the drug-resistant L. major; moreover, the roles of these proteins probably enhanced the parasite resistance to the drug and increased parasite survival in the cells.

Keywords: 2- Dimensional Gel Electrophoresis; Iran; Leishmania major; Meglumine Antimoniate (Glucantime®); Proteome map; Resistant; Sensitive

References

  1. Proteomics. 2001 Apr;1(4):461-72 - PubMed
  2. Proteomics. 2002 Jul;2(7):877-9 - PubMed
  3. Mol Cell Proteomics. 2003 Mar;2(3):146-55 - PubMed
  4. Biomedica. 2003 Jun;23(2):153-60 - PubMed
  5. Int J Dermatol. 2004 Apr;43(4):281-3 - PubMed
  6. Mol Cell Proteomics. 2005 Apr;4(4):582-93 - PubMed
  7. Clin Diagn Lab Immunol. 2005 Feb;12(2):310-20 - PubMed
  8. Science. 2005 Jul 15;309(5733):436-42 - PubMed
  9. Natl Med J India. 2005 May-Jun;18(3):131-3 - PubMed
  10. East Mediterr Health J. 2004 Jul-Sep;10(4-5):591-9 - PubMed
  11. Clin Microbiol Rev. 2006 Jan;19(1):111-26 - PubMed
  12. PLoS Med. 2006 May;3(5):e162 - PubMed
  13. Braz J Infect Dis. 2006 Feb;10(1):1-6 - PubMed
  14. Mol Cell Proteomics. 2007 Jan;6(1):88-101 - PubMed
  15. Anal Biochem. 1991 Jul;196(1):80-3 - PubMed
  16. J Med Microbiol. 2007 Feb;56(Pt 2):143-53 - PubMed
  17. Acta Trop. 2007 Jul;103(1):33-40 - PubMed
  18. Cell Microbiol. 2007 Nov;9(11):2586-97 - PubMed
  19. Mol Biochem Parasitol. 2008 Jun;159(2):85-91 - PubMed
  20. Curr Med Chem. 2009;16(5):599-614 - PubMed
  21. East Mediterr Health J. 2012 Feb;18(2):165-71 - PubMed
  22. PLoS One. 2012;7(5):e35671 - PubMed
  23. Iran J Parasitol. 2012;7(1):45-52 - PubMed
  24. Exp Parasitol. 2013 Oct;135(2):344-9 - PubMed
  25. Korean J Parasitol. 2013 Aug;51(4):413-9 - PubMed
  26. Biomed Res Int. 2013;2013:789326 - PubMed
  27. Iran J Parasitol. 2013 Jul;8(3):359-66 - PubMed
  28. Infect Genet Evol. 2014 Aug;26:203-12 - PubMed
  29. Iran J Med Sci. 2016 May;41(3):209-16 - PubMed
  30. Anal Chem. 1996 Mar 1;68(5):850-8 - PubMed
  31. J Immunol. 1997 Jun 1;158(11):5374-83 - PubMed
  32. Anal Biochem. 1976 May 7;72:248-54 - PubMed

Publication Types